Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing

As biomanufacturers face increasing pressure to deliver higher titers, faster timelines, and consistent quality, traditional batch models often struggle to keep pace. Continuous biomanufacturing offers a compelling alternative — but only when upstream and downstream processes are truly integrated, automated, and scalable.

MaruX™ reimagines end-to-end production through a modular, fully disposable platform that connects intensified cell culture with streamlined downstream operations. Automated, operator-independent controls enable seamless material transfer while preserving sterility and minimizing human error. Flexible configurations support extended run times, rapid reconfiguration, and smooth transitions between fed-batch and continuous processing, helping teams adapt to shifting product demands without compromising quality or regulatory confidence.

Advanced buffer management, simplified chromatography, and functionally closed flow paths contribute to improved productivity, reduced facility footprints, and more sustainable operations. By enabling semi-continuous and consecutive-batch processing, the platform supports high-density perfusion cultures while maintaining strong bioburden control and lot-specific analytics.

Explore how a fully integrated approach to continuous manufacturing can deliver greater agility, efficiency, and control — setting a new standard for modern bioproduction.